Factors affecting perfusionists' decisions on equipment utilization: Results of a United States survey

Journal of Extra-Corporeal Technology

Volumn 32, Issue 1, 2000, Pages 4-10

  Stammers, Alfred H ^a   Mejak, Brian L ^a   Rauch, Eric D ^a   Vang, See N ^a   Viessman, Thomas W ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Cost reduction; Perfusion accidents; Safety; Urvey

Indexed keywords

CONFERENCE PAPER; EXTRACORPOREAL CIRCULATION; HUMAN; INSTRUMENTATION; OPEN HEART SURGERY; PERFUSION; UNITED STATES;

EID: 0034019217     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Mejak BL, Stammers AH, Rauch E, Vang S, Viessman T. A retrospective study on perfusion accidents and safety devices. Perfusion 2000;15:51-61.
2. Thys DM. Can our patients afford the cost of cost containment? J Cardiothorac Vase Anesth. 1994;8:487-89.
3. Kassirer JP, Angell M. The journal's policy on cost-effective analyses. N Eng J Med. 1994;331:669-70.
4. Warren KS, Mosteller F. Doing more good than harm. The evaluation of health care interventions. Ann NY Acad Sci. 1993;703:1-341.
5. Groom RC, Hill AG, Kurusz M, et al. Paediatric perfusion practice in North America: An update. Perfusion 1995;10: 393-401.
6. Perfusion Practice Survey. Per Life. 1994;June:42-45.
7. Silvay G, Ammar T, Reich DL, et al. Cardiopulmonary bypass for adult patients: A survey of equipment and techniques. J Cardiothorac Vase Anesth. 1995;9:420-424.
8. Stoney WS, Alford WC, Burrus GR, Glassford DM, Thomas CS. Air embolism and other accidents using pump oxygenators. Ann Thorac Surg. 1980;29:336-340.
9. Kurusz M, Conti VR, Arens JF, et al. Perfusion accident survey. Proc Am Acad Cardiovasc Perf. 1986;7:57-65.
10. Jenkins OF, Morris R, Simpson JM. Australian perfusion incident survey. Perfusion 1997;12:279-288.
11. Stammers AH. Monitoring controversies during cardiopulmonary bypass: How far have we come? Perfusion 1998; 13:35-43.
12. Hsu LC. Biocompatibility in cardiopulmonary bypass. J Cardiothorac Vase Anesth. 1997;11:376-382.
13. Stammers AH, Huffman S, Alonso A, et al. The anti-inflammatory effects of aprotinin in patients undergoing cardiac surgery. J Extra-Corp Tech. 1997;29:114-122.
14. Hill, GE, Alonso A, Spurzem JR, Stammers AH, Robbins RA. Aprotinin and Methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in man. J Thorac Cardiovasc Surg, 1995;110:1658-62.
15. Mauldin PD, Wentraub WS, Becker ER. Predicting hospital costs for first time coronary artery bypass grafting from preoperative and postoperative variables. Am J Cardiol. 1994;74:772-75.